The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.
D000477:Alkylating Agents / Q000627:therapeutic use; D006585:Altretamine / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008727:Methotrexate / Q000627:therapeutic use; D011882:Radiotherapy, High-Energy; D011883:Radium / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D014626:Vaginal Smears
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001761:Bleomycin; D003520:Cyclophosphamide; D006585:Altretamine; D005472:Fluorouracil; D011883:Radium; D008727:Methotrexate